Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Dionysia Kefala"'
Autor:
Memnon Lysandrou, Panagiota Stamou, Dionysia Kefala, Chryso Pierides, Maria Kyriakou, Nikolaos Savvopoulos, Panayiota Christofi, Anastasia Papadopoulou, Evangelia Yannaki, Paul Costeas, Alexandros Spyridonidis
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Regulatory T cells (Tregs) are essential mediators of tolerance mitigating aberrant immune responses. While naturally occurring Treg (nTreg) development and function are directed by epigenetic events, induced Treg (iTreg) identity and mechanisms of a
Externí odkaz:
https://doaj.org/article/80fc168eb3404feb869437c92403f181
Autor:
Memnon Lysandrou, Dionysia Kefala, Panayiota Christofi, Penelope Georgia Papagianni, Antonis Mingos, Chryso Pieridou, Elisavet Vlachonikola, Maria Kyriakou, Alexandra Lydia Chatzidaniil, Nikolaos Savvopoulos, Anastasia Papadopoulou, Anastasia Chatzidimitriou, Paul Costeas, Evangelia Yannaki, Alexandros Spyridonidis
Publikováno v:
HemaSphere, Vol 7, p e41871bb (2023)
Externí odkaz:
https://doaj.org/article/f156db0ae42c42a48dccd9c824688788
Autor:
Memnon Lysandrou, Dionysia Kefala, Panayiota Christofi, Nikolaos Savvopoulos, Penelope Georgia Papayanni, Rodanthy Theodorellou, Eleftheria Sagiadinou, Vassiliki Zacharioudaki, Maria Moukouli, Dimitrios Tsokanas, Georgios Karavalakis, Maria Liga, Konstantinos Stavrinos, Anastasia Papadopoulou, Evangelia Yannaki, Alexandros Spyridonidis
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
Regulatory T-cell (Treg) immunotherapy has emerged as a promising and highly effective strategy to combat graft-versus-host disease (GvHD) after allogeneic hematopoietic cell transplantation (allo-HCT). Both naturally occurring Treg and induced Treg
Externí odkaz:
https://doaj.org/article/187b6f1c1162432fb2fde83824ed0734
Autor:
Afroditi Katsarou, Maria Sjöstrand, Jyoti Naik, Jorge Mansilla-Soto, Dionysia Kefala, Georgios Kladis, Alexandros Nianias, Ruud Ruiter, Renée Poels, Irene Sarkar, Yash R. Patankar, Elena Merino, Rogier M. Reijmers, Kristine A. Frerichs, Huipin Yuan, Joost de Bruijn, Dina Stroopinsky, David Avigan, Niels W. C. J. van de Donk, Sonja Zweegman, Tuna Mutis, Michel Sadelain, Richard W. J. Groen, Maria Themeli
Publikováno v:
Sci Transl Med
Katsarou, A, Sjöstrand, M, Naik, J, Mansilla-Soto, J, Kefala, D, Kladis, G, Nianias, A, Ruiter, R, Poels, R, Sarkar, I, Patankar, Y R, Merino, E, Reijmers, R M, Frerichs, K A, Yuan, H, de Bruijn, J, Stroopinsky, D, Avigan, D, van de Donk, N W C J, Zweegman, S, Mutis, T, Sadelain, M, Groen, R W J & Themeli, M 2021, ' Combining a CAR and a chimeric costimulatory receptor enhances T cell sensitivity to low antigen density and promotes persistence ', Science Translational Medicine, vol. 13, no. 623, pp. eabh1962 . https://doi.org/10.1126/scitranslmed.abh1962
Science Translational Medicine, 13(623). American Association for the Advancement of Science
Katsarou, A, Sjöstrand, M, Naik, J, Mansilla-Soto, J, Kefala, D, Kladis, G, Nianias, A, Ruiter, R, Poels, R, Sarkar, I, Patankar, Y R, Merino, E, Reijmers, R M, Frerichs, K A, Yuan, H, de Bruijn, J, Stroopinsky, D, Avigan, D, van de Donk, N W C J, Zweegman, S, Mutis, T, Sadelain, M, Groen, R W J & Themeli, M 2021, ' Combining a CAR and a chimeric costimulatory receptor enhances T cell sensitivity to low antigen density and promotes persistence ', Science Translational Medicine, vol. 13, no. 623, pp. eabh1962 . https://doi.org/10.1126/scitranslmed.abh1962
Science Translational Medicine, 13(623). American Association for the Advancement of Science
Despite the high remission rates achieved using T cells bearing a chimeric antigen receptor (CAR) against hematogical malignancies, there is still a considerable proportion of patients who eventually experience tumor relapse. Clinical studies have es
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::765463c7f1b19d6ab9e114dacaf8699c
https://europepmc.org/articles/PMC9869449/
https://europepmc.org/articles/PMC9869449/